Imaging of cardiac neuronal and receptor function

Journal of Nuclear Cardiology

Volumn 4, Issue 6, 1997, Pages 553-554

  Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; RECEPTOR; TRACER;

ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; BIOCHEMISTRY; EDITORIAL; HEART; IMAGING; LUNG; MONOCYTE; NEUROTRANSMISSION; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0031466507     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(97)90015-5     Document Type: Editorial

References (14)

1. Bristow M, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing heart. N Engl J Med 1982; 307:205-7.
2. Cohn JN, Levine B, Olivary MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
3. Munch G, Ziegler S, Nguyen N, et al. Scintigraphic evaluation of cardiac autonomic innervation. J Nucl Cardiol 1996;3:265-27.
4. CIBIS Investigor and Committee. A randomized trial of β-blockade in heart failure; the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994;90:1765-73.
5. Sisson JC, Shapiro B, Meyers L, et al. Meta-iodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987;28:1625-36.
6. Dae MW, O'Connell JW, Botvinick EH, et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 1989;79:634-44.
7. Schwaiger M, Kalff V, Rosenepire K, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 1990;82:457-64.
8. Deforge J, Syrota A, Lancon JP, et al. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J Nucl Med 1991;32:739-48.
9. Merlet P, Defolge J, Syrota A, et al. Positron emission tomography with UC CGP-12177 to assess beta-adrenergic receptor concentration in idiolathoc dilated cardiomnyopathy. Circulation 1993; 87:1169-78.
10. Lefroy DC, deSilva R, Choudhury L, et al. Diffuse reduction of myocardial beta-adrenoreceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J Am Coll Cardiol 1993;22:1653-60.
11. Brisow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human heart. N Engl J Med 1982;307:205-11.
12. Martinsson A, Larsson K, Hjemdahl P. Stueis in vivo ands in vitro terbutaline-induced beta-adrenoceptor desensitization in healthy subjects. Clin Sci 1987;72:47-54.
13. Hayes MJ, Qing F, Rhodes CG, et al. In vivo quantification of human pulmonary β-adrenoceptors: effect of β-agonist therapy. Am J Respir Crit Care Med 1996;154:1277-83.
14. Qing F, Rahman SU, Hayes MJ, et al. Effect of chronic β2-agonist dosing on human cardiac β-adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte β-receptors. J Nucl Cardiol 1997;4:532-8.